Currently, out of the existing stock ratings of Gregg Gilbert - 162 which are a Buy (70.74%), 65 which are a Hold (28.38%), 2 which are a Sell (0.87%)

Gregg Gilbert

Work Performance Price Targets & Ratings Chart

Analyst Gregg Gilbert works at BAML and is covering the Healthcare sector with 461 price targets and ratings displayed on 26 stocks. Previously, Gregg Gilbert worked at DEUTSCHE BANK.

Gregg Gilbert's average stock forecast success ratio is 67.13% with an average time for price targets to be met of 272.81 days.

Most recent stock forecast was given on BMY, BristolMyers Squibb Company at 15-Sep-2023.

Wall Street Analyst Gregg Gilbert

Analyst best performing recommendations are on LCI (LANNETT COMPANY).
The best stock recommendation documented was for LCI (LANNETT COMPANY) at 8/29/2019. The price target of $40 was fulfilled within 1 day with a profit of $4.48 (12.61%) receiving and performance score of 126.13.

Average potential price target upside

of $28.77 (16.01%) on AGN.
of $27.95 (21.99%) on LLY (ELI LILLY AND COMPANY).
of $27.3 (20.73%) on JAZZ (JAZZ PHARMACEUTICALS PLC).

ABBV AbbVie AGN AKRX AMAG ARQT Arcutis Biotherapeutics ATRS Antares Pharma BHC Bausch Health Companies ENDP Endo International plc EOLS Evolus JAZZ Jazz Pharmaceuticals plc LCI Lannett Company LGND Ligand Pharmaceuticals LLY Eli Lilly and Company MNK MRK Merck . MYL NVCR NovoCure PFE Pfizer PRGO Perrigo Company plc TEVA Teva Pharmaceutical Industries ZTS Zoetis BMY BristolMyers Squibb Company COLL Collegium Pharmaceutical AMRX Amneal Pharmaceuticals VTRS SGNT

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Christopher Raymond (PIPER SANDLER)